EXEYX
Price
$16.14
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RGEBX
Price
$73.96
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

EXEYX vs RGEBX

Header iconEXEYX vs RGEBX Comparison
Open Charts EXEYX vs RGEBXBanner chart's image
Manning & Napier Equity Series S
Price$16.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.96
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
EXEYX vs RGEBX Comparison Chart
Loading...
VS
EXEYX vs. RGEBX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEYX is a StrongBuy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. EXEYX (71.9M). RGEBX pays higher dividends than EXEYX: RGEBX (0.16) vs EXEYX (0.13). EXEYX was incepted earlier than RGEBX: EXEYX (26 years) vs RGEBX (10 years). EXEYX is a more actively managed with annual turnover of: 35.00 vs. RGEBX (31.00). RGEBX has a lower initial minimum investment than EXEYX: RGEBX (250) vs EXEYX (2000). RGEBX (22.86) and EXEYX (22.06) have marching annual gain over last year. RGEBX return over 5 years is better than : 47.60 vs. EXEYX (16.52).
EXEYXRGEBXEXEYX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years10 years-
Gain YTD13.57518.89672%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets71.9M284B0%
Annual Yield % from dividends0.130.1682%
Returns for 1 year22.0622.8697%
Returns for 3 years-11.58-4.80242%
Returns for 5 years16.5247.6035%
Returns for 10 years-26.1656.25-47%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics